Evidence map›Paper›PMID 38020610›Full record

ArticleFrontiers in neurology2023

The dual-path hypothesis for the emergence of anosognosia in Alzheimer's disease.

Katia Andrade, Thomas Guieysse, Takfarinas Medani, Etienne Koechlin, Dimitrios Pantazis, Bruno Dubois

Open access · goldAbstract read
In one paragraph

Article in Frontiers in neurology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 2 countries.

Katia AndradeInstitute of Memory and Alzheimer's Disease (IM2A), Department of Neurology, Assistance Publique-Hôpitaux de Paris (AP-HP), Sorbonne University, Pitié-Salpêtrière Hospital, Paris, France.
Thomas GuieysseInstitute of Memory and Alzheimer's Disease (IM2A), Department of Neurology, Assistance Publique-Hôpitaux de Paris (AP-HP), Sorbonne University, Pitié-Salpêtrière Hospital, Paris, France.
Takfarinas MedaniSignal and Image Processing Institute, University of Southern California, Los Angeles, CA, United States.
Etienne KoechlinÉcole Normale Supérieure, Laboratoire de Neurosciences Cognitives et Computationnelles, Paris, France.
Dimitrios PantazisMcGovern Institute for Brain Research, Massachusetts Institute of Technology, Cambridge, MA, United States.
Bruno DuboisInstitute of Memory and Alzheimer's Disease (IM2A), Department of Neurology, Assistance Publique-Hôpitaux de Paris (AP-HP), Sorbonne University, Pitié-Salpêtrière Hospital, Paris, France.
Assistance Publique – Hôpitaux de Paris · FRLaboratoire de Neurosciences Cognitives et ComputationnellesMassachusetts Institute of Technology · USSorbonne Université · FRUniversity of Southern California · US

Funding

Digital Biomarkers for Vascular Cognitive Decline in Patients with Minor StrokeRF1AG079324 · NIA · JOHNS HOPKINS UNIVERSITY · PI MARSH, ELISABETH BREESE, MOSHER, JOHN COMPTON · 2022 to 2025
$3.8M
Digital biomarker for a low cost ambulatory test for early detection of Alzheimer's diseaseRF1AG074204 · NIA · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI FUNKE, MICHAEL, MOSHER, JOHN COMPTON · 2021 to 2021
$2.1M
NIA NIH HHS RF1 AG074204NIA NIH HHS RF1 AG079324
6 · The paper itself

Abstract

Although neurocognitive models have been proposed to explain anosognosia in Alzheimer's disease (AD), the neural cascade responsible for its origin in the human brain remains unknown. Here, we build on a mechanistic dual-path hypothesis that brings error-monitoring and emotional processing systems as key elements for self-awareness, with distinct impacts on the emergence of anosognosia in AD. Proceeding from the notion of anosognosia as a dimensional syndrome, varying between a lack of concern about one's own deficits (i.e., anosodiaphoria) and a complete lack of awareness of deficits, our hypothesis states that (i) unawareness of deficits would result from primary damage to the error-monitoring system, whereas (ii) anosodiaphoria would more likely result from an imbalance between emotional processing and error-monitoring. In the first case, a synaptic failure in the error-monitoring system, in which the anterior and posterior cingulate cortices play a major role, would have a negative impact on error (or deficits) awareness, preventing patients from becoming aware of their condition. In the second case, an impairment in the emotional processing system, in which the amygdala and the orbitofrontal cortex play a major role, would prevent patients from monitoring the internal milieu for relevant errors (or deficits) and assigning appropriate value to them, thus biasing their impact on the error-monitoring system. Our hypothesis stems on two scientific premises. One comes from preliminary results in AD patients showing a synaptic failure in the error-monitoring system along with a decline of awareness for cognitive difficulties at the time of diagnosis. Another comes from the somatic marker hypothesis, which proposes that emotional signals are critical to adaptive behavior. Further exploration of these premises will be of great interest to illuminate the foundations of self-awareness and improve our knowledge of the underlying paths of anosognosia in AD and other brain disorders.

Indexed as

Alzheimer’s diseaseanosognosiaemotional processingerror-monitoring systemerror-related potentialsneural mechanismself-awarenesssynaptic failure

Identifiers

PMID38020610
PMCPMC10654627
OpenAlexW4388303233

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.